Tirzepatide (Mounjaro)
Tirzepatide (Mounjaro)
Treatment as low as $800 per month. Call today to learn more.
Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist, representing a new class of medicines studied for the treatment of obesity. Tirzepatide is a single peptide that triggers the body's receptors for GIP and GLP-1, two natural incretin hormones. Cyanocobalamin will help increase energy.
GIP has decreased food intake and increased energy expenditure, resulting in weight reductions. Combined with a GLP-1 receptor agonist, it has a more significant effect on glucose and body weight effects.
Substantial A1C reductions
Boosted weight loss
Improvements in cardiometabolic measures
Reduce appetite
Reduce Constipation
Less side effects than Semaglutide
Less adverse effects on gastric indigestion
Providing weight loss results comparable to bariatric surgery
According to studies, one-third of those on Mounjaro lose 25% of their body weight.
Any medical weight loss program you use can be combined with others.
In the interest of the health and safety of our clients and staff, we installed a Steril-Aire system that provides ultraviolet germicidal irradiation. This disinfection method uses short-wavelength ultraviolet light to kill or inactivate microorganisms by destroying nucleic acids and disrupting their DNA, leaving them unable to perform vital cellular functions. Viruses that are airborne can be safeguarded against with high doses of UVC in the airstream, and research shows it kills 99% of airborne viruses. Additionally, this system is environmentally friendly and produces no ozone or secondary contaminants.
- Monday-Friday8:45 am-6:30 pm
- Free Parking AvailableClosed on Weekends
Powered by: 
